# Early vs. interval approach to laparoscopic cholecystectomy for acute cholecystitis: a retrospective observational study from Pakistan

**Authors:** Sandesh Raja, Azzam Ali, Dileep Kumar, Adarsh Raja, Khursheed Ahmed Samo, Amjad Siraj Memon

PMC · DOI: 10.3389/fsurg.2024.1462885 · Frontiers in Surgery · 2024-09-06

## TL;DR

A study in Pakistan compared early and delayed surgery for gallbladder inflammation, finding fewer complications with early surgery.

## Contribution

The study provides local evidence on optimal timing for laparoscopic cholecystectomy in acute cholecystitis management.

## Key findings

- Early cholecystectomy had fewer operative complications (12%) compared to interval cholecystectomy (34%).
- No significant differences were found in operative time or postoperative hospital stay between the groups.

## Abstract

Laparoscopic cholecystectomy (LC) is the preferred treatment for acute cholecystitis (AC). However, the optimal timing for LC in AC management remains uncertain, with early cholecystectomy (EC) and interval cholecystectomy (IC) being two common approaches influenced by various factors.

This retrospective study, conducted at a tertiary care teaching hospital in Karachi, Pakistan, aimed to compare the outcomes of EC vs. IC for AC management. Patient data from January 2019 to September 2019 were analyzed with a focus on operative complications, duration of surgery, and postoperative hospital stay. The inclusion criteria were based on the Tokyo Guidelines, and patients underwent LC within 3 days of symptom onset in the EC group and after 6 weeks in the IC group.

Among 147 eligible patients, 100 underwent LC (50 in each group). No significant differences were observed in the sex distribution or mean age between the two groups. The EC group experienced fewer operative complications (12%) than the IC group (34%), with statistically significant differences observed. Nevertheless, no substantial variations in operative time or postoperative hospital stay were observed between the groups.

Reduced complications in the EC group underscore its safety and efficacy. Nonetheless, further validation through multicenter studies is essential to substantiate these findings.

## Linked entities

- **Diseases:** acute cholecystitis (MONDO:0002155)

## Full-text entities

- **Diseases:** AC (MESH:D041881)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11412953/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11412953/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC11412953/full.md

---
Source: https://tomesphere.com/paper/PMC11412953